Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenazopyridine HCl for uUTI Pain
NCT01650051Phase 3Completed
- Sponsor
- Amneal Pharmaceuticals, Inc.
- Start
- Feb 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urinary tract infection (UTI) comparing Placebo with Phenazopyridine Hydrochloride (2 arms). Primary endpoint: Severity of pain upon urination at 24 hours. Started Feb 2012; status: completed.
02
Drugs
phenazopyridine
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT01650051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01650051.